Skip to main content

2% Lidocaine Hydrochloride Topical Jelly Shortage

Last Updated: September 26, 2023
Status: Current

Products Affected - Description
    • Lidocaine Hydrochloride topical jelly, Akorn, 2%, 30 mL tube, 1 count, NDC 17478-0711-30 - discontinued
    • Lidocaine Hydrochloride topical jelly, Akorn, 2%, 5 mL tube, 10 count, NDC 17478-0711-31 - discontinued
Reason for the Shortage
    • Akorn ceased operations in February 2023.
    • Amphastar is releasing Uro-Jet supplies regularly.
    • Sagent has Glydo syringes available.
Available Products
    • Glydo topical jelly, Sagent, 2%, 11 mL syringe, 10 count, NDC 25021-0673-77
    • Glydo topical jelly, Sagent, 2%, 6 mL syringe, 10 count, NDC 25021-0673-76
    • Uro-Jet topical jelly, Amphastar, 2%, 10 mL syringe, 25 count, NDC 76329-3013-05
    • Uro-Jet topical jelly, Amphastar, 2%, 20 mL syringe, 25 count, NDC 76329-3015-05
    • Uro-Jet topical jelly, Amphastar, 2%, 5 mL syringe, 25 count, NDC 76329-3012-05
    • Uro-Jet topical jelly, Amphastar, 2%, 5 mL syringe, 25 count, NDC 76329-3011-05

Updated

Updated September 26, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 10, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer